Olema Pharmaceuticals annual return on equity
2020
2021
2022
2023
2024
2025
Olema Pharmaceuticals Return on Equity (ROE) Growth & History (OLMA)
Olema Pharmaceuticals's return on equity was −36.61% for fiscal 2025.
View full Olema Pharmaceuticals company overviewOlema Pharmaceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −36.61% | +2.46 pp |
| 2024 | 2024-12-31 | −39.07% | +3.76 pp |
| 2023 | 2023-12-31 | −42.82% | +0.65 pp |
| 2022 | 2022-12-31 | −43.47% | −20.64 pp |
| 2021 | 2021-12-31 | −22.83% | −9.33 pp |
| 2020 | 2020-12-31 | −13.51% | — |
Olema Pharmaceuticals quarterly return on equity
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −13.87% | −1.86 pp |
| Q1 2026 | 2026-03-31 | −11.07% | −3.40 pp |
| Q4 2025 | 2025-12-31 | −11.72% | −0.68 pp |
| Q3 2025 | 2025-09-30 | −12.94% | +3.28 pp |
| Q2 2025 | 2025-06-30 | −12.02% | +1.09 pp |
| Q1 2025 | 2025-03-31 | −7.67% | +4.97 pp |
| Q4 2024 | 2024-12-31 | −11.04% | −0.92 pp |
| Q3 2024 | 2024-09-30 | −16.22% | −6.37 pp |
| Q2 2024 | 2024-06-30 | −13.11% | −1.17 pp |
| Q1 2024 | 2024-03-31 | −12.64% | +2.55 pp |
| Q4 2023 | 2023-12-31 | −10.12% | +2.49 pp |
| Q3 2023 | 2023-09-30 | −9.85% | +0.16 pp |
| Q2 2023 | 2023-06-30 | −11.94% | +1.17 pp |
| Q1 2023 | 2023-03-31 | −15.19% | −6.81 pp |
| Q4 2022 | 2022-12-31 | −12.61% | −5.22 pp |
| Q3 2022 | 2022-09-30 | −10.01% | −4.25 pp |
| Q2 2022 | 2022-06-30 | −13.11% | −7.98 pp |
| Q1 2022 | 2022-03-31 | −8.38% | −3.76 pp |
| Q4 2021 | 2021-12-31 | −7.39% | −1.21 pp |
| Q3 2021 | 2021-09-30 | −5.76% | — |
| Q2 2021 | 2021-06-30 | −5.13% | — |
| Q1 2021 | 2021-03-31 | −4.62% | — |
| Q4 2020 | 2020-12-31 | −6.19% | — |
Olema Pharmaceuticals return on equity trends
Over the last five fiscal years, Olema Pharmaceuticals's return on equity decreased from −13.51% to −36.61%, a change of −23.10 percentage points. The latest reported quarter, Q2 2026, shows −13.87%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Olema Pharmaceuticals source filings ↗